Dark Blue Therapeutics Revenue
Biotechnology Research • 
Oxford, England, United Kingdom • 11-20 Employees
Dark Blue Therapeutics revenue & valuation
| Annual revenue | $1,711,100 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,500,000 |
| Total funding | No funding |
Key Contacts at Dark Blue Therapeutics
Sarah Major
Director Of Medicinal Chemistry
Craig Fox
Board Director
Graham Craggs
Director Of Translational And Mechanistic Biology
Alastair Mackinnon
Chief Executive Officer
Company overview
| Headquarters | Hayakawa Building, Robert Robinson Avenue,, Oxford, England OX4 4GB, GB |
| Phone number | +441865803112 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Biomarkers, Pharmaceuticals, Oncology, Drug Discovery, Precision Medicine, Immunooncology, Dna Damage Repair |
| Founded | 2020 |
| Employees | 11-20 |
| Socials |
Dark Blue Therapeutics Email Formats
Dark Blue Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@darkbluetx.com), used 55% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@darkbluetx.com | 55% |
{first initial}{last name} | jdoe@darkbluetx.com | 45% |
About Dark Blue Therapeutics
Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies. Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK. We have assembled a highly experienced team, whose expertise spans the breadth of drug development from discovery to approval. This expertise has been gained over many years in the industry and draws from biotech, large pharmaceutical companies and investment management. Dark Blue leverages ground-breaking cancer biology insights, from Oxford University, to discover and develop innovative precision medicines that exploit novel vulnerabilities and dependencies. With this deep, proprietary understanding of target biology we match our precision medicines to molecularly defined patient populations to develop transformative, durable drugs that address critical unmet patient needs, delivering medicines that transform the outcomes for cancer patients. We work across a variety of biological mechanisms to identify and pursue only cancer targets that have the highest transformative potential.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Dark Blue Therapeutics has 12 employees across 6 departments.
Departments
Number of employees
Funding Data
Dark Blue Therapeutics has never raised funding before.
Dark Blue Therapeutics Tech Stack
Discover the technologies and tools that power Dark Blue Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Tag managers
Hosting
Webmail
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
Page builders
JavaScript libraries
Miscellaneous
United Arab Emirates
United States
Frequently asked questions
4.8
40,000 users
